A Chicago startup that seeks to 3-D print human hearts for transplantation has added to its scientific advisory board of heavy hitters. But just how close is the company to producing its first viable heart?
An Indiana company is the first to win permission from FDA to market a device for use in helping to reduce the symptoms of opioid withdrawal.
Merit Medical Systems said it will pay $100 million for assets in connection with BD and C.R. Bard's $24 billion merger.
FDA cleared Cianna Medical's Savi Scout reflector for breast cancer conservation surgery without restrictions on the length of time the implant can remain in the breast.
New guidelines urge use of dressings with an FDA-cleared label that specifies a clinical indication for reducing catheter-related bloodstream infection or catheter-associated bloodstream infection.
FDA is warning the public about the dangers of using injectable silicone that is falsely marketed as FDA-approved dermal fillers for cosmetic enhancement.
In its annual list of Health Technology Hazards, the ECRI Institute points to the risks posed by ransomware and cybercrime.
The company now has CE mark for its Intellis platform for both Spinal Cord Stimulation and Peripheral Nerve Stimulation as an aid in the management of certain types of chronic pain.
First study findings of Intuitive Surgical's flexible robotics platform suggest it provides a safe and practical approach for sampling lung tissue.
BD still plans to enter the estimated $1 billion market for insulin patch pumps for patients with type 2 diabetes, but its first product won't launch as soon as the company initially anticipated.
FDA and Philips reached an agreement regarding manufacturing issues involving the company's automatic external defibrillators.
After a six-year hiatus from the coronary stent business, Cordis just inked an exclusive distribution deal for two heart stents.